Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Angelini

Showing results (281-290 of 531) with videos related to

Pageof 54
Sort By:
Metabolism: Clinical and Experimental|September 1, 1987
Glucose and ketone body turnover in carnitine-palmitoyl-transferase deficiencyR Nosadini, C Angelini, C Trevisan, et al.
Neurobiology of Disease|August 30, 2011
Aberrant splicing and expression of the non muscle myosin heavy-chain gene MYH14 in DM1 muscle tissuesF Rinaldi, C Terracciano, V Pisani, et al.
Nature Genetics|November 1, 1995
Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complexC G Bönnemann, R Modi, S Noguchi, et al.
Gene|January 28, 2006
Intronic breakpoint definition and transcription analysis in DMD/BMD patients with deletion/duplication at the 5' mutation hot spot of the dystrophin geneF Gualandi, P Rimessi, C Trabanelli, et al.
Muscle & Nerve|April 16, 1999
Heart involvement in muscular dystrophies due to sarcoglycan gene mutationsP Melacini, M Fanin, D J Duggan, et al.
Human Molecular Genetics|January 1, 1996
A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathyJ Milasin, F Muntoni, G M Severini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 21, 2005
Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathyS Benedetti, E Bertini, S Iannaccone, et al.
American Journal of Human Genetics|August 12, 1999
A stop-codon mutation in the human mtDNA cytochrome c oxidase I gene disrupts the functional structure of complex IVC Bruno, A Martinuzzi, Y Tang, et al.
Journal of Managed Care & Specialty Pharmacy|July 31, 2018
An Evaluation of a Multidisciplinary Pediatric Behavioral Health Medication Initiative Workgroup's Interventions on Medication Prescribing in a Population of Medicaid PatientsAshley N Chiara, Neha Kashalikar, Thomas C Pomfret, et al.
Chemico-Biological Interactions|November 1, 2005
Interaction between organophosphate compounds and cholinergic functions during developmentM G Aluigi, C Angelini, C Falugi, et al.
Pageof 54

Showing results (281-290 of 531) with videos related to

Sort By:
Pageof 54
Metabolism: Clinical and Experimental|September 1, 1987
Glucose and ketone body turnover in carnitine-palmitoyl-transferase deficiencyR Nosadini, C Angelini, C Trevisan, et al.
Neurobiology of Disease|August 30, 2011
Aberrant splicing and expression of the non muscle myosin heavy-chain gene MYH14 in DM1 muscle tissuesF Rinaldi, C Terracciano, V Pisani, et al.
Nature Genetics|November 1, 1995
Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complexC G Bönnemann, R Modi, S Noguchi, et al.
Gene|January 28, 2006
Intronic breakpoint definition and transcription analysis in DMD/BMD patients with deletion/duplication at the 5' mutation hot spot of the dystrophin geneF Gualandi, P Rimessi, C Trabanelli, et al.
Muscle & Nerve|April 16, 1999
Heart involvement in muscular dystrophies due to sarcoglycan gene mutationsP Melacini, M Fanin, D J Duggan, et al.
Human Molecular Genetics|January 1, 1996
A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathyJ Milasin, F Muntoni, G M Severini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 21, 2005
Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathyS Benedetti, E Bertini, S Iannaccone, et al.
American Journal of Human Genetics|August 12, 1999
A stop-codon mutation in the human mtDNA cytochrome c oxidase I gene disrupts the functional structure of complex IVC Bruno, A Martinuzzi, Y Tang, et al.
Journal of Managed Care & Specialty Pharmacy|July 31, 2018
An Evaluation of a Multidisciplinary Pediatric Behavioral Health Medication Initiative Workgroup's Interventions on Medication Prescribing in a Population of Medicaid PatientsAshley N Chiara, Neha Kashalikar, Thomas C Pomfret, et al.
Chemico-Biological Interactions|November 1, 2005
Interaction between organophosphate compounds and cholinergic functions during developmentM G Aluigi, C Angelini, C Falugi, et al.
Pageof 54